<http://schema.org/description>
"(HealthDay)\u2014For patients with preexisting occlusive vascular disease, the combination of niacin and the anti-flushing agent laropiprant provides no benefit and is associated with an increase in serious side effects, according to a study presented at the annual meeting of the American College of Cardiology, held from March 9 to 11 in San Francisco."^^<http://www.w3.org/2001/XMLSchema#string>
<http://medicalxpress.com/news/2013-03-acc-niacinlaropiprant-benefit-vascular-disease.html>